Diagnostic efficacy of the secretin stimulation test for the Zollinger-Ellison Syndrome: An intra-individual comparison using different dosages in patients and controls

Pancreatology

Volumn 10, Issue 1, 2010, Pages 14-18

  Kuiper, Patricia ^a   Biemond, Izäk ^a   Masclee, Ad A ^a   Jansen, Jan B ^b   Verspaget, Hein W ^a   Lamers, Cornelis B ^c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Gastrin; Gastrinoma; Hypergastrinemia; Secretin

Indexed keywords

GASTRIN; SECRETIN;

ADULT; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG DOSE COMPARISON; FEMALE; HORMONAL REGULATION; HUMAN; MALE; PRIORITY JOURNAL; PROVOCATION TEST; STATISTICAL ANALYSIS; VALIDATION STUDY; ZOLLINGER ELLISON SYNDROME;

EID: 77951463348     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000265936     Document Type: Article

References (16)

1. Zollinger RM, Ellison EH: Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas. Ann Surg 1955; 142: 709-728.
2. Jensen RT: Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas. Basic Clin Pharmacol Toxicol 2006; 98: 4-19.
3. Murugesan SV, Varro A, Pritchard DM: Review article: strategies to determine whether hypergastrinaemia is due to Zollinger-Ellison syndrome rather than a more common benign cause. Aliment Pharmacol Ther 2009; 29: 1055-1068.
4. Berna MJ, Hoffmann KM, Serrano J, Gibril F, Jensen RT: Serum gastrin in Zollinger-Ellison syndrome. I. Prospective study of fasting serum gastrin in 309 patients from the National Institutes of Health and comparison with 2,229 cases from the literature. Medicine (Baltimore) 2006; 85: 295-330.
5. Berna MJ, Hoffmann KM, Long SH, Serrano J, Gibril F, Jensen RT: Serum gastrin in Zollinger-Ellison syndrome. II. Prospective study of gastrin provocative testing in 293 patients from the National Institutes of Health and comparison with 537 cases from the literature: evaluation of diagnostic criteria, proposal of new criteria, and correlations with clinical and tumoral features. Medicine (Baltimore) 2006; 85: 331-364.
6. Malagelada JR, Glanzman SL, Go VL: Laboratory diagnosis of gastrinoma. II. A prospective study of gastrin challenge tests. Mayo Clin Proc 1982; 57: 219-226.
7. Matsui T, Iida M, Nanbu T, Kohrogi N: A study of secretin dosage of secretin provocation test in the Zollinger-Ellison syndrome. Nippon Shokakibyo Gakkai Zasshi 1985; 82: 288-295.
8. Yamamoto C, Aoyagi K, Iwata K, Morita I, Hotekezaka M, Funakoshi S, Sakamoto K, Iida M, Sakisaka S: Double doses of secretin contribute to diagnosis of Zollinger-Ellison syndrome in secretin and selective arterial secretion injection tests - a case report. Dig Dis Sci 2005; 50: 2034-2036.
9. Mignon M, Rigaud D, Cambray S, Chayvialle JA, Accary JP, René E, Vatier J, Bonfils S: A comparative evaluation of secretin bolus and secretin infusion as secretin provocation tests in the Zollinger-Ellison syndrome. Scand J Gastroenterol 1985; 20: 791-797.
10. McGuigan JE, Wolfe MM: Secretin injection test in the diagnosis of gastrinoma. Gastroenterology 1980; 79: 1324-1331.
11. Lamers CB: Clinical usefulness of the secretin provocation test. J Clin Gastroenterol 1981; 3: 255-259.
12. Deveney CW, Deveney KS, Jaffe BM, Jones RS, Way LW: Use of calcium and secretin in the diagnosis of gastrinoma (Zollinger-Ellison syndrome). Ann Intern Med 1977; 87: 680-686.
13. Lamers CB, Van Tongeren JH: Comparative study of the value of calcium, secretin, and meal stimulated increase in serum gastrin in the diagnosis of the Zollinger-Ellison syndrome. Gut 1977; 18: 128-135.
14. Modlin IM, Jaffe BM, Sank A, Albert D: The early diagnosis of gastrinoma. Ann Surg 1982; 196: 512-517.
15. Hirschowitz BI, Simmons J, Mohnen J: Longterm lansoprazole control of gastric acid and pepsin secretion in ZE and non-ZE hypersecretors: a prospective 10-year study. Aliment Pharmacol Ther 2001; 15: 1795-1806.
16. Goldman JA, Blanton WP, Hay DW, Wolfe MM: False-positive secretin stimulation test for gastrinoma associated with the use of proton pump inhibitor therapy. Clin Gastroenterol Hepatol 2009; 7: 600-602.